Simvastatin treatment reduces the cholesterol content of membrane/lipid rafts, implicating the N -methyl-D-aspartate receptor in anxiety: a literature review. (2017). Brazilian Journal of Pharmaceutical Sciences, 53(1), e16102-. https://doi.org/10.1590/s2175-97902017000116102